Skip to Content
Merck

Key Documents

View All Documentation

729094

Poly(ethylene glycol) diacrylate

average Mn 10,000, acrylate, MEHQ as inhibitor (may contain)

Synonym(s):

Polyethylene glycol, PEG diacrylate

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

CAS Number:
26570-48-9
NACRES:
NA.23
UNSPSC Code:
12162002
MDL number:
MFCD00081876
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Poly(ethylene glycol) diacrylate, average Mn 10,000, contains MEHQ as inhibitor

form

solid

Quality Level

100

mol wt

average Mn 10,000

contains

MEHQ as inhibitor, ≤1,500 ppm MEHQ as inhibitor (may contain)

reaction suitability

reagent type: cross-linking reagent
reaction type: Polymerization Reactions

transition temp

Tm 60-64 °C

Mw/Mn

<1.1

Ω-end

acrylate

α-end

acrylate

polymer architecture

shape: linear
functionality: homobifunctional

storage temp.

−20°C

SMILES string

OCCO.OC(=O)C=C

InChI

1S/C8H10O4/c1-3-7(9)11-5-6-12-8(10)4-2/h3-4H,1-2,5-6H2

InChI key

KUDUQBURMYMBIJ-UHFFFAOYSA-N

Application

  • 3D Bioprinting of Hydrogels: This study explores the formulation of PEGDA-based hydrogels for 3D bioprinting, focusing on rheological properties and structural fidelity, particularly relevant for tissue engineering applications (Wu et al., 2018).
  • Sustained Ocular Drug Delivery: Investigates the delivery of small and large drug molecules using PEGDA implants, highlighting the implications for sustained drug release in ocular therapies (McAvoy et al., 2018).
  • Tissue Engineering Scaffolds: Evaluates PEGDA-polycaprolactone scaffolds for tissue engineering, emphasizing the control over porosity and its importance for regenerative medicine applications (Kotturi et al., 2017).
  • Photocrosslinked Hydrogel Implants: Focuses on photocrosslinked PEGDA implants for drug delivery, providing insights into the design of drug delivery systems that can be finely tuned for specific therapeutic needs (Qin et al., 2015).
  • Hydrogel-Based Artificial Muscles: Characterizes PEGDA/acrylic acid hydrogels optimized for use as artificial muscles, highlighting their potential in biomedical engineering and smart materials (Browe et al., 2017).

Preparation Note

Synthesized with an initial concentration of ≤1,500 ppm MEHQ

Still not finding the right product?

Explore all of our products under Poly(ethylene glycol) diacrylate

pictograms

CorrosionExclamation mark
GHS05,GHS07

signalword

Danger

Hazard Classifications

Eye Dam. 1 - Skin Irrit. 2 - Skin Sens. 1

Storage Class

11 - Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
MKDB1194
MKCW4404
MKCS6711
MKCN5525
MKCN4021

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Ruohong Shi et al.
Small (Weinheim an der Bergstrasse, Germany), 16(37), e2002946-e2002946 (2020-08-11)
Hydrogels with the ability to change shape in response to biochemical stimuli are important for biosensing, smart medicine, drug delivery, and soft robotics. Here, a family of multicomponent DNA polymerization motor gels with different polymer backbones is created, including acrylamide-co-bis-acrylamide